
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : RHX-317
Therapeutic Area : Immunology
Study Phase : IND Enabling
Sponsor : Rheos Medicines
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The goal of the collaboration is to provide biological resources from HSC patients in order to evaluate MALT1-targeted therapeutics, including Rheos’s lead product candidate, RHX-317, for Graft-versus-Host Disease, based on functional immunologic profi...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
October 27, 2021
Lead Product(s) : RHX-317
Therapeutic Area : Immunology
Highest Development Status : IND Enabling
Sponsor : Rheos Medicines
Deal Size : Undisclosed
Deal Type : Collaboration
